Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Bensen

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Canadian Medical Association Journal|November 15, 1982
HLA-B8 and erythema nodosumG H Guyatt, W G Bensen, L P Stolmon, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1992
Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritisN Bellamy, W G Bensen, P M Ford, et al.
The Journal of Rheumatology|October 1, 1985
Gold induced aplastic anemiaJ D Adachi, W G Bensen, M Ali, et al.
The Journal of Rheumatology|May 1, 1979
Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseasesW G Bensen, C A Laskin, T W Paton, et al.
Annals of the Rheumatic Diseases|August 1, 1990
Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuriaD P Singal, B Reid, D Green, et al.
Lancet (London, England)|November 14, 1987
HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritisD P Singal, M D'Souza, B Reid, et al.
The Journal of Rheumatology|February 7, 1998
Fluoride therapy in prevention of rheumatoid arthritis induced bone lossJ D Adachi, M J Bell, W G Bensen, et al.
The Journal of Rheumatology|December 1, 1987
Low dose cyclosporine in rheumatoid arthritis: a pilot studyP Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology|August 24, 2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placeboW G Bensen, S Z Zhao, T A Burke, et al.
The Journal of Rheumatology|October 1, 1994
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone lossJ Adachi, A Cranney, C H Goldsmith, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Canadian Medical Association Journal|November 15, 1982
HLA-B8 and erythema nodosumG H Guyatt, W G Bensen, L P Stolmon, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1992
Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritisN Bellamy, W G Bensen, P M Ford, et al.
The Journal of Rheumatology|October 1, 1985
Gold induced aplastic anemiaJ D Adachi, W G Bensen, M Ali, et al.
The Journal of Rheumatology|May 1, 1979
Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseasesW G Bensen, C A Laskin, T W Paton, et al.
Annals of the Rheumatic Diseases|August 1, 1990
Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuriaD P Singal, B Reid, D Green, et al.
Lancet (London, England)|November 14, 1987
HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritisD P Singal, M D'Souza, B Reid, et al.
The Journal of Rheumatology|February 7, 1998
Fluoride therapy in prevention of rheumatoid arthritis induced bone lossJ D Adachi, M J Bell, W G Bensen, et al.
The Journal of Rheumatology|December 1, 1987
Low dose cyclosporine in rheumatoid arthritis: a pilot studyP Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology|August 24, 2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placeboW G Bensen, S Z Zhao, T A Burke, et al.
The Journal of Rheumatology|October 1, 1994
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone lossJ Adachi, A Cranney, C H Goldsmith, et al.
Pageof 5